Last reviewed · How we verify

Hylorel (GUANADREL)

Pfizer · FDA-approved approved Small molecule Quality 25/100

Hylorel (Guanadrel) is a small molecule drug developed by Pharmacia and Upjohn that targets the alpha-1A adrenergic receptor. It is classified as a guanadrel and was FDA approved in 1982 for the treatment of hypertensive disorders. As an off-patent medication, there are currently no generic manufacturers. Key safety considerations include its potential effects on blood pressure and heart rate. Hylorel is a vasodilator that works by blocking the alpha-1A adrenergic receptor, leading to decreased peripheral resistance and lowered blood pressure.

At a glance

Generic nameGUANADREL
SponsorPfizer
Drug classguanadrel
TargetAlpha-1A adrenergic receptor
ModalitySmall molecule
Therapeutic areaCardiovascular
PhaseFDA-approved
First approval1982

Approved indications

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions